FDA Inspection 1181106 — Awawu Igbinadolor
The FDA completed an inspection of Awawu Igbinadolor on Sep 22, 2022 in Monroe, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 22, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Monroe, NC (United States)
Additional Details
Clinical Investigator (CI)